• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国献血者中 SARS-CoV-2 抗体的流行率。

The prevalence of antibodies to SARS-CoV-2 among blood donors in China.

机构信息

National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, P.R. China.

Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, P.R. China.

出版信息

Nat Commun. 2021 Mar 2;12(1):1383. doi: 10.1038/s41467-021-21503-x.

DOI:10.1038/s41467-021-21503-x
PMID:33654063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7925561/
Abstract

In this study, we investigate the seroprevalence of SARS-CoV-2 antibodies among blood donors in the cities of Wuhan, Shenzhen, and Shijiazhuang in China. From January to April 2020, 38,144 healthy blood donors in the three cities were tested for total antibody against SARS-CoV-2 followed by pseudotype SARS-CoV-2 neutralization tests, IgG, and IgM antibody testing. Finally, a total of 398 donors were confirmed positive. The age- and sex-standardized SARS-CoV-2 seroprevalence among 18-60 year-old adults (18-65 year-old in Shenzhen) was 2.66% (95% CI: 2.24%-3.07%) in Wuhan, 0.033% (95% CI: 0.0029%-0.267%) in Shenzhen, and 0.0028% (95% CI: 0.0001%-0.158%) in Shijiazhuang, respectively. Female sex and older-age were identified to be independent risk factors for SARS-CoV-2 seropositivity among blood donors in Wuhan. As most of the population of China remained uninfected during the early wave of the COVID-19 pandemic, effective public health measures are still certainly required to block viral spread before a vaccine is widely available.

摘要

在这项研究中,我们调查了中国武汉、深圳和石家庄三个城市献血者中 SARS-CoV-2 抗体的血清流行率。2020 年 1 月至 4 月,对三个城市的 38144 名健康献血者进行了 SARS-CoV-2 总抗体检测,随后进行了假型 SARS-CoV-2 中和试验、IgG 和 IgM 抗体检测。最终,共有 398 名献血者被确认为阳性。在年龄和性别标准化后,18-60 岁成年人(深圳为 18-65 岁)的 SARS-CoV-2 血清流行率在武汉为 2.66%(95%CI:2.24%-3.07%),在深圳为 0.033%(95%CI:0.0029%-0.267%),在石家庄为 0.0028%(95%CI:0.0001%-0.158%)。在武汉,女性和高龄是献血者 SARS-CoV-2 血清阳性的独立危险因素。由于中国大部分人口在 COVID-19 大流行的早期阶段没有感染,因此在广泛使用疫苗之前,仍然需要采取有效的公共卫生措施来阻止病毒传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b48/7925561/27acdf57b03a/41467_2021_21503_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b48/7925561/feef8acb0e61/41467_2021_21503_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b48/7925561/12eec2ecd926/41467_2021_21503_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b48/7925561/02aa54581b7a/41467_2021_21503_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b48/7925561/27acdf57b03a/41467_2021_21503_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b48/7925561/feef8acb0e61/41467_2021_21503_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b48/7925561/12eec2ecd926/41467_2021_21503_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b48/7925561/02aa54581b7a/41467_2021_21503_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b48/7925561/27acdf57b03a/41467_2021_21503_Fig4_HTML.jpg

相似文献

1
The prevalence of antibodies to SARS-CoV-2 among blood donors in China.中国献血者中 SARS-CoV-2 抗体的流行率。
Nat Commun. 2021 Mar 2;12(1):1383. doi: 10.1038/s41467-021-21503-x.
2
SARS-CoV-2 antibody kinetics in blood donors with a previously positive SARS-CoV-2 antibody test within a seroprevalence survey.在一项血清流行率调查中,对先前 SARS-CoV-2 抗体检测呈阳性的献血者的 SARS-CoV-2 抗体动力学进行研究。
J Med Virol. 2022 Apr;94(4):1711-1716. doi: 10.1002/jmv.27486. Epub 2021 Dec 8.
3
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign.中国武汉 SARS-CoV-2 免疫球蛋白抗体的血清流行率:全市大规模检测活动的一部分。
Clin Microbiol Infect. 2021 Feb;27(2):253-257. doi: 10.1016/j.cmi.2020.09.044. Epub 2020 Oct 7.
4
Screening and Analysis of SARS-CoV-2 Antibody Among Unvaccinated Blood Donors in Chongqing, China.中国重庆未接种疫苗献血者中 SARS-CoV-2 抗体的筛查与分析。
Disaster Med Public Health Prep. 2024 May 3;18:e85. doi: 10.1017/dmp.2023.232.
5
Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors.通过对献血者血液中抗 SARS-CoV-2 IgG/IgM 抗体的血清阳性率分析来评估厄瓜多尔的 COVID-19 疫情进展。
Front Cell Infect Microbiol. 2024 Jun 21;14:1373450. doi: 10.3389/fcimb.2024.1373450. eCollection 2024.
6
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.伊朗 18 个城市一般人群和高风险职业人群中 SARS-CoV-2 抗体血清流行率:一项基于人群的横断面研究。
Lancet Infect Dis. 2021 Apr;21(4):473-481. doi: 10.1016/S1473-3099(20)30858-6. Epub 2020 Dec 15.
7
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.SARS-CoV-2 血清流行率趋势在 COVID-19 爆发期间在米兰的健康献血者中。
Blood Transfus. 2021 May;19(3):181-189. doi: 10.2450/2021.0324-20. Epub 2021 Feb 3.
8
Low prevalence of antibodies against SARS-CoV-2 among voluntary blood donors in Guangzhou, China.中国广州无偿献血者中 SARS-CoV-2 抗体的低流行率。
J Med Virol. 2021 Mar;93(3):1743-1747. doi: 10.1002/jmv.26445. Epub 2020 Sep 30.
9
Seroprevalence of IgM and IgG Antibodies against SARS-CoV-2 in Asymptomatic People in Wuhan: Data from a General Hospital Near South China Seafood Wholesale Market during March to April in 2020.2020 年 3 月至 4 月期间,位于华南海鲜批发市场附近的一家综合医院对无症状人群的 SARS-CoV-2 血清 IgM 和 IgG 抗体的阳性率:来自武汉的研究数据。
Biomed Environ Sci. 2021 Sep 20;34(9):743-749. doi: 10.3967/bes2021.103.
10
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.加拿大第一波 COVID-19 疫情后献血者中的 SARS-CoV-2 血清流行率。
Transfusion. 2021 Mar;61(3):862-872. doi: 10.1111/trf.16296. Epub 2021 Feb 23.

引用本文的文献

1
Comparison of Infection-Induced SARS-CoV-2 Seroprevalence Across Large-Scale Residual Samples From Blood Donors, Commercial Laboratories, and Health Checkups in Japan, 2023.2023年日本献血者、商业实验室和健康检查的大规模剩余样本中感染诱导的新冠病毒血清流行率比较
Open Forum Infect Dis. 2025 Jul 17;12(8):ofaf415. doi: 10.1093/ofid/ofaf415. eCollection 2025 Aug.
2
Interpreting the Influence of Using Blood Donor Residual Samples for SARS-CoV-2 Seroprevalence Studies in Japan: Cross-Sectional Survey Study.解读日本使用献血者剩余样本进行SARS-CoV-2血清流行率研究的影响:横断面调查研究
JMIR Public Health Surveill. 2025 Feb 10;11:e60467. doi: 10.2196/60467.
3

本文引用的文献

1
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.针对 SARS-CoV-2 感染的强大中和抗体可长期存在。
Science. 2020 Dec 4;370(6521):1227-1230. doi: 10.1126/science.abd7728. Epub 2020 Oct 28.
2
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China.中国武汉 SARS-CoV-2 抗体血清阳性率。
JAMA Netw Open. 2020 Oct 1;3(10):e2025717. doi: 10.1001/jamanetworkopen.2020.25717.
3
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign.
Structural insight into broadening SARS-CoV-2 neutralization by an antibody cocktail harbouring both NTD and RBD potent antibodies.
通过含有 NTD 和 RBD 强效抗体的抗体鸡尾酒拓宽对 SARS-CoV-2 的中和作用的结构见解。
Emerg Microbes Infect. 2024 Dec;13(1):2406300. doi: 10.1080/22221751.2024.2406300. Epub 2024 Nov 27.
4
Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic.遗传追踪新冠疫情中心的市场野生动物和病毒。
Cell. 2024 Sep 19;187(19):5468-5482.e11. doi: 10.1016/j.cell.2024.08.010.
5
A quadri-fluorescence SARS-CoV-2 pseudovirus system for efficient antigenic characterization of multiple circulating variants.一种用于高效鉴定多种循环变异株的四荧光 SARS-CoV-2 假病毒系统。
Cell Rep Methods. 2024 Sep 16;4(9):100856. doi: 10.1016/j.crmeth.2024.100856. Epub 2024 Sep 6.
6
Seroprevalence of COVID-19 among voluntary blood donors.无偿献血者中新冠病毒病的血清流行率。
Asian J Transfus Sci. 2024 Jan-Jun;18(1):97-101. doi: 10.4103/ajts.ajts_91_23. Epub 2023 Nov 7.
7
A cryptic site in class 5 epitope of SARS-CoV-2 RBD maintains highly conservation across natural isolates.严重急性呼吸综合征冠状病毒2受体结合域(SARS-CoV-2 RBD)5类表位中的一个隐蔽位点在天然分离株中保持高度保守。
iScience. 2024 Jun 11;27(7):110208. doi: 10.1016/j.isci.2024.110208. eCollection 2024 Jul 19.
8
Exploring cell-free assays for COVID-19 serosurvey.探索用于 COVID-19 血清学调查的无细胞检测方法。
Sci Rep. 2024 Mar 13;14(1):6096. doi: 10.1038/s41598-024-55852-6.
9
Serological surveillance reveals a high exposure to SARS-CoV-2 and altered immune response among COVID-19 unvaccinated Cameroonian individuals.血清学监测显示,喀麦隆未接种新冠疫苗的个体中,新冠病毒暴露率高且免疫反应发生改变。
PLOS Glob Public Health. 2024 Feb 12;4(2):e0002380. doi: 10.1371/journal.pgph.0002380. eCollection 2024.
10
COVID-19 in a Portuguese whole blood donor population.葡萄牙全血献血者群体中的新冠病毒 2019 感染情况。
Heliyon. 2023 Oct 2;9(11):e20570. doi: 10.1016/j.heliyon.2023.e20570. eCollection 2023 Nov.
中国武汉 SARS-CoV-2 免疫球蛋白抗体的血清流行率:全市大规模检测活动的一部分。
Clin Microbiol Infect. 2021 Feb;27(2):253-257. doi: 10.1016/j.cmi.2020.09.044. Epub 2020 Oct 7.
4
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.COVID-19 患者血清和唾液中针对 SARS-CoV-2 刺突抗原的抗体反应持续存在。
Sci Immunol. 2020 Oct 8;5(52). doi: 10.1126/sciimmunol.abe5511.
5
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.SARS-CoV-2 感染后中和抗体和 T 细胞应答的持久性。
Front Med. 2020 Dec;14(6):746-751. doi: 10.1007/s11684-020-0822-5. Epub 2020 Oct 5.
6
Humoral Immune Response to SARS-CoV-2 in Iceland.冰岛人针对 SARS-CoV-2 的体液免疫反应。
N Engl J Med. 2020 Oct 29;383(18):1724-1734. doi: 10.1056/NEJMoa2026116. Epub 2020 Sep 1.
7
Age-dependent effects in the transmission and control of COVID-19 epidemics.年龄相关因素对 COVID-19 疫情传播和防控的影响。
Nat Med. 2020 Aug;26(8):1205-1211. doi: 10.1038/s41591-020-0962-9. Epub 2020 Jun 16.
8
Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.武汉 COVID-19 患者炎症反应和结局的性别影响。
J Med Virol. 2020 Nov;92(11):2684-2692. doi: 10.1002/jmv.26137. Epub 2020 Jun 19.
9
Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?新冠病毒感染中的性别差异。雌激素对上下呼吸道的影响。它能否有助于找到一种治疗方法?
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5195-5196. doi: 10.26355/eurrev_202005_21298.
10
COVID-19 and ABO blood group: another viewpoint.新型冠状病毒肺炎与ABO血型:另一种观点。
Br J Haematol. 2020 Jul;190(2):e93-e94. doi: 10.1111/bjh.16884. Epub 2020 Jun 8.